Actively Recruiting
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
Led by Maternal and Child Health Hospital of Hubei Province · Updated on 2025-07-10
150
Participants Needed
1
Research Sites
47 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
By comparing the application effects of three drugs in pediatric preoperative sedation, this study explores the optimal medication regimen, aiming to provide safer, more effective, and more personalized medication options for pediatric preoperative sedation. Additionally, this research will also focus on the impact of these three drugs on postoperative agitation in children, offering valuable references for the overall management of pediatric surgical anesthesia.
CONDITIONS
Official Title
Application of Remimazolam, Dexmedetomidine, and Esketamine in Pediatric Preoperative Sedation
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 2 to 5 years old
- Classified as American Society of Anesthesiologists (ASA) physical status Class I
- Scheduled for adenotonsillectomy under general anesthesia
You will not qualify if you...
- Abnormal lung or respiratory system function
- Airway obstruction or deformity
- History of mental illness
- Electrocardiogram showing bradycardia
- History of cardiac disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Maternal and Child Health Hospital of Hubei Province
Wuhan, Hubei, China, 430000
Actively Recruiting
Research Team
N
NaLi, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here